BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11799927)

  • 1. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
    Marshall JR
    Nutr Cancer; 2001; 40(1):74-7. PubMed ID: 11799927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
    Clark LC; Marshall JR
    Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
    Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
    Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
    Jiang L; Yang KH; Tian JH; Guan QL; Yao N; Cao N; Mi DH; Wu J; Ma B; Yang SH
    Nutr Cancer; 2010; 62(6):719-27. PubMed ID: 20661819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium and prostate cancer prevention.
    Nelson MA; Porterfield BW; Jacobs ET; Clark LC
    Semin Urol Oncol; 1999 May; 17(2):91-6. PubMed ID: 10332922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
    Kim J; Sun P; Lam YW; Troncoso P; Sabichi AL; Babaian RJ; Pisters LL; Pettaway CA; Wood CG; Lippman SM; McDonnell TJ; Lieberman R; Logothetis C; Ho SM
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1697-702. PubMed ID: 16030104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
    Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
    Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
    Platz EA; Lippman SM
    J Clin Oncol; 2009 Aug; 27(22):3569-72. PubMed ID: 19528369
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.
    Hartman TJ; Albanes D; Pietinen P; Hartman AM; Rautalahti M; Tangrea JA; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):335-40. PubMed ID: 9568790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial.
    Chlebowski RT; Menon R; Chaisanguanthum RM; Jackson DM
    Clin Trials; 2010 Dec; 7(6):744-8. PubMed ID: 20833684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
    Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.